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   A case of pheochromocytoma of the urinary bladder was reported．
    A 43－year－old man visited us with chief complaint of gross hematuria， The physical examination
was essentially negative except for hypertension （ISOIIOO mmHg）． IVP demonstrated normal upper
urinary tract but a filling defect in the bladder． Cystoscopic examination revealed a non－villous
and broad based tumor in the anterior bladder wa］1． With the diagnosis of bladder tumor trans－
urethral snare resection of the tumor was performed． During the resection blood pressure rose to
254／150 mmHg and dropped to 180／100 mmHg by the injection ofphentolamine 5 mg． Catecholamine
Ievels in the 24 hour urine of the following day were abnormally elevated． The histological diagnosis
was pheochromocytoma of the urlnary bladder． Following the histological report a皿ore detailed
history was taken from the patient． For five years he had experienced headache and palpitation
after miction and those episodes had gradually increased． The patient was subsequently operated
upon and a partial cystectomy was performed． Postoperatively a normal voiding pattern was resumed
without spells， but hypertension persisted． A24 hour catecholal皿ine lcvels were slightly elevated on
the 7th postoperative day． The patient was discharged on the 26th postoperative day． At present
he is asymptomatic except for hypertension．
    The literature was reviewed briefly about pleochromocytoma of the urinary bladder．

































血球数7900／mm3， Hb 15．79／dl， Ht 45．3％，血沈：
1時間値2mm，2時間値7mm，血液化学：総蛋白
7．5gldl， GOT 38 mU／ml， GPT 37 mU／ml， Al－P
67uU／ml， T－bilirubin O．9 mg／dl， BUN 13mgfdl，
creatinine 1．2 mg／dl， FBs l l 7 mg／dl， Na 143 mEq／1，









Fig． 1． DIP shows the filling defect in the



















































































Fig． 2． Cut surface of gross specimen after the potassium
    dichromate fixation． The tumor was seen to
    extend into the muscle layer in a lobulated form．
712 泌尿紀要 27巻 6号 1981年
Fig． 3． The tumor was composed ofovoid and polygonal
    cells arranged in a trabecular fashion and
    separated by thin walled vascular spaces．
    （H ＆ E． ×100）
Fig． 5．The tumor cells had abundant brown granules
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Table 1． Pheochromocytomas of the u血ary bladder in the Japanese literature
bO 報告者  年齢・性 主訴 血尿 高血圧騨治療法 備 考
      6）
1 勝ヒ目。ほか  49．♀
      21）
2 田崎・ほか  66．♂
3 新山・ほか 58．♀
      劉
4 新保・ほか  17．♀
5 秋田・ほか 59．♂
      罰
6 勝見・ほか  59．♂
      5｝
7 高橋・ほか 52．♀
      9）
8  dヒJll・1まカ＞   62．♂
      2）







心悸充進    （一） （＋） （一）多 汗
二二（・）（一）（一）
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抗悪性腫瘍剤     ．           ［函
フ1一『ヲフ岡，V．
’縁顯懲fi灘蘂垂雛垂蕪
1．フトラフールは主に肝臓で活性化され、活性物質である5－FU、FUR、
 FUMPの濃度が長時間持続します。この長時間持続性は代謝拮抗剤
 による癌化学療法において極めて重要なことです。
2．フトラフールはmasked compoundのため、副作用が軽微で、長期連続
 投与が可能です。
3．初回治療にも非初回治療にも有効であり、癌イζ学療法における寛
 解導入のみならず、寛解強化療法、寛解維持療法として使用され
特に病理組織学的に腺癌と診断された症例に有効です6
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